Is paromomycin the drug of choice for eradication of Blastocystis in adults?

Journal of Infection and Chemotherapy

Volumn 19, Issue 3, 2013, Pages 545-548

  Van Hellemond, Jaap J ^a   Molhoek, Nicky ^b   Koelewijn, Rob ^b   Wismans, Pieter J ^b   Van Genderen, Perry J J ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Harbour Hospital   (Netherlands)

Author keywords

Blastocystis; Chronic gastrointestinal complaints; Clioquinol; Diarrhea; Metronidazole; Paromomycin

Indexed keywords

CLIOQUINOL; METRONIDAZOLE; PAROMOMYCIN;

ADULT; ARTICLE; BLASTOCYSTOSIS; COHORT ANALYSIS; CONTROLLED STUDY; DRUG CHOICE; DRUG EFFICACY; DRUG RESPONSE; ERADICATION THERAPY; FECES ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOME ASSESSMENT; PARASITE CLEARANCE; RETROSPECTIVE STUDY;

EID: 84879198141     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0496-2     Document Type: Article

References (15)

1. Tan KS. New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin Microbiol Rev. 2008;21:639-65.
2. Stensvold CR, Smith HV, Nagel R, Olsen KE, Traub RJ. Eradication of Blastocystis carriage with antimicrobials: reality or delusion? J Clin Gastroenterol. 2010;44:85-90.
3. Tan KS, Mirza H, Teo JD, Wu B, Macary PA. Current views on the clinical relevance of Blastocystis spp. Curr Infect Dis Rep. 2010;12:28-35.
4. Stensvold CR, Nielsen HV, Molbak K, Smith HV. Pursuing the clinical significance of Blastocystis - diagnostic limitations. Trends Parasitol. 2009;25:23-9.
5. Stensvold CR, Alfellani M, Clark CG. Levels of genetic diversity vary dramatically between Blastocystis subtypes. Infect Genet Evol. 2012;12:263-73.
6. Coyle CM, Varughese J, Weiss LM, Tanowitz HB. Blastocystis: to treat or not to treat. Clin Infect Dis. 2012;54:105-10.
7. Hassing RJ, Wismans PJ, Koelewijn R, van Hellemond JJ, van Genderen PJJ. Comment on: frequency of enteric protozoan parasites among patients with gastrointestinal complaints in medical centers of Zahedan, Iran. Trans R Soc Trop Med Hyg 2009;103:1292-3 (author reply 1293-4).
8. Roberts T, Barratt J, Harkness J, Ellis J, Stark D. Comparison of microscopy, culture, and conventional polymerase chain reaction for detection of Blastocystis sp. in clinical stool samples. Am J Trop Med Hyg. 2011;84:308-12.
9. Rossignol JF, Kabil SM, Said M, Samir H, Younis AM. Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis. Clin Gastroenterol Hepatol. 2005;3:987-91.
10. Nigro L, Larocca L, Massarelli L, Patamia I, Minniti S, Palermo F, et al. A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole. J Travel Med. 2003;10:128-30.
11. Heyland K, Friedt M, Buehr P, Braegger CP. No advantage for antibiotic treatment over placebo in Blastocystis hominis-positive children with recurrent abdominal pain. J Pediatr Gastroenterol Nutr. 2012;54:677-9.
12. van Gool T, Weijts R, Lommerse E, Mank TG. Triple Faeces Test: an effective tool for detection of intestinal parasites in routine clinical practice. Eur J Clin Microbiol Infect Dis. 2003;22:284-90.
13. Mirza H, Teo JD, Upcroft J, Tan KS. A rapid, high-throughput viability assay for Blastocystis spp. reveals metronidazole resistance and extensive subtype-dependent variations in drug susceptibilities. Antimicrob Agents Chemother. 2011;55:637-48.
14. Stenzel DJ, Boreham PF. Blastocystis hominis revisited. Clin Microbiol Rev. 1996;9:563-84.
15. van Hellemond JJ, Molhoek N, Koelewijn R, Wismans PJ, van Genderen PJJ. Is paromomycin the drug of choice for eradication of Dientamoeba fragilis in adults? Int J Parasitol Drugs Drug Resist. 2012;2:162-5.